Patents by Inventor CECILIA CHIU

CECILIA CHIU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11084877
    Abstract: The invention provides anti-CLL-1 antibodies and immunoconjugates and methods of using the same.
    Type: Grant
    Filed: January 17, 2019
    Date of Patent: August 10, 2021
    Assignee: Genentech, Inc.
    Inventors: Bing Zheng, Andrew Polson, Cecilia Chiu, Wei-Ching Liang, Yan Wu
  • Publication number: 20190248903
    Abstract: The invention provides anti-CLL-1 antibodies and immunoconjugates and methods of using the same.
    Type: Application
    Filed: January 17, 2019
    Publication date: August 15, 2019
    Applicant: Genentech, Inc.
    Inventors: Bing ZHENG, Andrew Polson, Cecilia Chiu, Wei-Ching Liang, Yan Wu
  • Patent number: 10266597
    Abstract: The invention provides anti-CLL-1 antibodies and immunoconjugates and methods of using the same.
    Type: Grant
    Filed: July 24, 2017
    Date of Patent: April 23, 2019
    Assignee: Genentech, Inc.
    Inventors: Bing Zheng, Andrew Polson, Cecilia Chiu, Wei-Ching Liang, Yan Wu
  • Patent number: 10239947
    Abstract: The invention provides anti-CLL-1 antibodies and immunoconjugates and methods of using the same.
    Type: Grant
    Filed: July 24, 2017
    Date of Patent: March 26, 2019
    Assignee: Genentech, Inc.
    Inventors: Bing Zheng, Andrew Polson, Cecilia Chiu, Wei-Ching Liang, Yan Wu
  • Patent number: 10227412
    Abstract: The invention provides anti-CLL-1 antibodies and immunoconjugates and methods of using the same.
    Type: Grant
    Filed: July 24, 2017
    Date of Patent: March 12, 2019
    Assignee: Genentech, Inc.
    Inventors: Bing Zheng, Andrew Polson, Cecilia Chiu, Wei-Ching Liang, Yan Wu
  • Publication number: 20190010228
    Abstract: The invention provides anti-LRP5 antibodies and methods of making and using the same.
    Type: Application
    Filed: June 26, 2018
    Publication date: January 10, 2019
    Applicant: Genentech, Inc.
    Inventors: Yan Wu, Weilan Ye, Jeremy Bryant Burton, Cecilia Chiu
  • Patent number: 10035854
    Abstract: The invention provides anti-LRP5 antibodies and methods of making and using the same.
    Type: Grant
    Filed: November 11, 2016
    Date of Patent: July 31, 2018
    Assignee: GENENTECH, INC.
    Inventors: Yan Wu, Weilan Ye, Jeremy Bryant Burton, Cecilia Chiu
  • Publication number: 20180044421
    Abstract: The invention provides anti-CLL-1 antibodies and immunoconjugates and methods of using the same.
    Type: Application
    Filed: July 24, 2017
    Publication date: February 15, 2018
    Applicant: Genentech, Inc.
    Inventors: Bing Zheng, Andrew Polson, Cecilia Chiu, Wei-Ching Liang, Yan Wu
  • Publication number: 20180044420
    Abstract: The invention provides anti-CLL-1 antibodies and immunoconjugates and methods of using the same.
    Type: Application
    Filed: July 24, 2017
    Publication date: February 15, 2018
    Applicant: Genentech, Inc.
    Inventors: Bing Zheng, Andrew Polson, Cecilia Chiu, Wei-Ching Liang, Yan Wu
  • Publication number: 20180009894
    Abstract: The invention provides anti-CLL-1 antibodies and immunoconjugates and methods of using the same.
    Type: Application
    Filed: July 24, 2017
    Publication date: January 11, 2018
    Applicant: Genentech, Inc.
    Inventors: Bing Zheng, Andrew Polson, Cecilia Chiu, Wei-Ching Liang, Yan Wu
  • Patent number: 9751946
    Abstract: The invention provides anti-CLL-1 antibodies and immunoconjugates and methods of using the same.
    Type: Grant
    Filed: September 11, 2015
    Date of Patent: September 5, 2017
    Assignee: Genentech, Inc.
    Inventors: Bing Zheng, Andrew Polson, Cecilia Chiu, Wei-Ching Liang, Yan Wu
  • Publication number: 20170166636
    Abstract: The invention provides anti-LRP5 antibodies and methods of making and using the same.
    Type: Application
    Filed: November 11, 2016
    Publication date: June 15, 2017
    Applicant: Genentech, Inc.
    Inventors: Yan Wu, Weilan Ye, Jeremy Bryant Burton, Cecilia Chiu
  • Patent number: 9522954
    Abstract: The invention provides anti-LRP5 antibodies and methods of making and using the same.
    Type: Grant
    Filed: October 9, 2015
    Date of Patent: December 20, 2016
    Assignee: GENENTECH, INC.
    Inventors: Yan Wu, Weilan Ye, Jeremy Bryant Burton, Cecilia Chiu
  • Publication number: 20160185855
    Abstract: The invention provides anti-LRP5 antibodies and methods of making and using the same.
    Type: Application
    Filed: October 9, 2015
    Publication date: June 30, 2016
    Applicant: GENENTECH INC.
    Inventors: Yan Wu, Weilan Ye, Jeremy Bryant Burton, Cecilia Chiu
  • Publication number: 20160075787
    Abstract: The invention provides anti-CLL-1 antibodies and immunoconjugates and methods of using the same.
    Type: Application
    Filed: September 11, 2015
    Publication date: March 17, 2016
    Applicant: GENENTECH, INC.
    Inventors: Bing Zheng, Andrew Polson, Cecilia Chiu, Wei-Ching Liang
  • Patent number: 9200072
    Abstract: The invention provides anti-LRP5 antibodies and methods of making and using the same.
    Type: Grant
    Filed: January 18, 2013
    Date of Patent: December 1, 2015
    Assignee: GENENTECH INC.
    Inventors: Yan Wu, Weilan Ye, Jeremy Bryant Burton, Cecilia Chiu
  • Publication number: 20120195910
    Abstract: The invention provides anti-PCSK9 antibodies and methods of using the same.
    Type: Application
    Filed: December 21, 2011
    Publication date: August 2, 2012
    Applicant: GENENTECH, INC.
    Inventors: YAN WU, CECILIA CHIU, DANIEL KIRCHHOFER, ANDREW PETERSON, GANESH KOLUMAM, MONICA KONG BELTRAN, PAUL MORAN, WEI LI